- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Gut-first Parkinson’s disease is encoded by gut dysbiome ; volume:19 ; number:1 ; day:24 ; month:10 ; year:2024 ; pages:1-28 ; date:12.2024
Molecular neurodegeneration ; 19, Heft 1 (24.10.2024), 1-28, 12.2024
- Creator
-
Munoz-Pinto, Mário F.
Candeias, Emanuel
Melo-Marques, Inês
Esteves, A. Raquel
Maranha, Ana
Magalhães, João D.
Carneiro, Diogo Reis
Sant’Anna, Mariana
Pereira-Santos, A. Raquel
Abreu, António E.
Nunes-Costa, Daniela
Alarico, Susana
Tiago, Igor
Morgadinho, Ana
Lemos, João
Figueiredo, Pedro N.
Januário, Cristina
Empadinhas, Nuno
Cardoso, Sandra Morais
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13024-024-00766-0
- URN
-
urn:nbn:de:101:1-2501132118358.444312681271
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Munoz-Pinto, Mário F.
- Candeias, Emanuel
- Melo-Marques, Inês
- Esteves, A. Raquel
- Maranha, Ana
- Magalhães, João D.
- Carneiro, Diogo Reis
- Sant’Anna, Mariana
- Pereira-Santos, A. Raquel
- Abreu, António E.
- Nunes-Costa, Daniela
- Alarico, Susana
- Tiago, Igor
- Morgadinho, Ana
- Lemos, João
- Figueiredo, Pedro N.
- Januário, Cristina
- Empadinhas, Nuno
- Cardoso, Sandra Morais
- SpringerLink (Online service)
Other Objects (12)
Parkinson’s Disease and Gut Microbiota
Disease progression in proposed brain-first and body-first Parkinson’s disease subtypes
Gut, oral and nasal microbiota and Parkinson’s disease
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Gut microbiota in Parkinson’s disease patients: hospital-based study
Gut microbiota helps identify clinical subtypes of Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
Investigating the aspect of asymmetry in brain-first versus body-first Parkinson’s disease
Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms
Diet and the gut microbiome in patients with Parkinson’s disease
Parkinson’s Disease and Gut Microbiota
Disease progression in proposed brain-first and body-first Parkinson’s disease subtypes
Gut, oral and nasal microbiota and Parkinson’s disease
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Gut microbiota in Parkinson’s disease patients: hospital-based study
Gut microbiota helps identify clinical subtypes of Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
Investigating the aspect of asymmetry in brain-first versus body-first Parkinson’s disease
Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms
Diet and the gut microbiome in patients with Parkinson’s disease
Parkinson’s Disease and Gut Microbiota
Disease progression in proposed brain-first and body-first Parkinson’s disease subtypes
Gut, oral and nasal microbiota and Parkinson’s disease
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Gut microbiota in Parkinson’s disease patients: hospital-based study
Gut microbiota helps identify clinical subtypes of Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
Investigating the aspect of asymmetry in brain-first versus body-first Parkinson’s disease
Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms